Alliance Wealth Advisors LLC UT Buys 63 Shares of STERIS plc (NYSE:STE)

Alliance Wealth Advisors LLC UT boosted its stake in shares of STERIS plc (NYSE:STE) by 1.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,878 shares of the medical equipment provider’s stock after buying an additional 63 shares during the quarter. Alliance Wealth Advisors LLC UT’s holdings in STERIS were worth $852,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Millburn Ridgefield Corp bought a new stake in STERIS during the 3rd quarter valued at about $25,000. Catalyst Capital Advisors LLC bought a new stake in STERIS during the 3rd quarter valued at about $25,000. Global Wealth Management Investment Advisory Inc. bought a new stake in STERIS during the 3rd quarter valued at about $49,000. NBC Securities Inc. bought a new stake in STERIS during the 3rd quarter valued at about $50,000. Finally, Exchange Traded Concepts LLC bought a new stake in STERIS during the 3rd quarter valued at about $54,000. Institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on STE shares. JMP Securities restated a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 8th. TheStreet upgraded shares of STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a report on Friday, April 12th. KeyCorp started coverage on shares of STERIS in a report on Tuesday, February 6th. They issued an “overweight” rating and a $253.00 price target for the company. Finally, Stephens restated an “overweight” rating and issued a $250.00 price target on shares of STERIS in a report on Friday, February 9th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $239.60.

STERIS Stock Up 1.2 %

Shares of STERIS stock traded up $2.36 on Friday, reaching $203.90. The stock had a trading volume of 318,142 shares, compared to its average volume of 558,812. The company has a 50 day moving average price of $221.18 and a 200 day moving average price of $216.80. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.50. STERIS plc has a 1 year low of $181.78 and a 1 year high of $254.00. The stock has a market capitalization of $20.15 billion, a P/E ratio of 35.71 and a beta of 0.79.

STERIS (NYSE:STE) last issued its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.17 by $0.05. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the previous year, the firm earned $2.02 EPS. The company’s quarterly revenue was up 14.8% compared to the same quarter last year. As a group, equities research analysts forecast that STERIS plc will post 8.67 EPS for the current year.

STERIS Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were given a dividend of $0.52 per share. This represents a $2.08 annualized dividend and a yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 22nd. STERIS’s dividend payout ratio is presently 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.